Saija, Carlo
Pradeep Kundur, Sukruth
Leung, Lisa
Sabu, Sachin
Pinto, Marco
Herridge, Mark
Gabbeta, Adharvan
Chavan, Rashi
Chowdry, Nadia
Gibson, Gregory
Byrne, Calum
Pontiki, Antonia
Housden, Richard James
Berthet-Rayne, Pierre
Behar, Jonathan M.
Rhode, Kawal
Funding for this research was provided by:
Wellcome Centre for Medical Engineering at King’s College London (WT203148/Z/16/Z)
British Heart Foundation (BHF) Centre of Excellence at King’s College London
Department of Health and Social Care (DHSC) through the National Institute for Health and Care Research (NIHR) MedTech
Vitro Diagnostic Co-operative (MIC) Award for Cardiovascular Diseases to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London (MIC-2016-019)
Caranx Medical
Article History
Received: 19 November 2024
Accepted: 3 September 2025
First Online: 7 October 2025
Declarations
:
: Author Carlo Saija was employed by the company Caranx Medical. Author Pierre Berthet-Ryne was employed by the company Caranx Medical. Author Marco Antonio Coutinho Pinto was employed by the company Biosense Webster. The remaining authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.